Novartis Vaccines and Diagnostics GmbH & Co. KG – Trademark Portfolio

Entity Type: 13

Novartis Vaccines and Diagnostics GmbH & Co. KG holds 14 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 14 filings in this category. Currently, 1 trademark is registered. Notable registered marks include RABAVERT. The owner is based in 35041 Marburg.

Emil-von-Behring-Strasse 76

35041 Marburg , DE

14 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Novartis Vaccines and Diagnostics GmbH & Co. KG's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (14 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Novartis Vaccines and Diagnostics GmbH & Co. KG have?

Novartis Vaccines and Diagnostics GmbH & Co. KG has 14 U.S. trademarks filed with the USPTO. Of these, 1 registered, 7 cancelled.

What trademark classes does Novartis Vaccines and Diagnostics GmbH & Co. KG file in?

Novartis Vaccines and Diagnostics GmbH & Co. KG files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Novartis Vaccines and Diagnostics GmbH & Co. KG's most well-known trademarks?

Novartis Vaccines and Diagnostics GmbH & Co. KG's registered trademark portfolio includes well-known marks such as RABAVERT. These are among 1 currently registered trademark in the portfolio.

What is Novartis Vaccines and Diagnostics GmbH & Co. KG's trademark registration success rate?

Novartis Vaccines and Diagnostics GmbH & Co. KG has a 13% trademark registration rate, with 1 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.